Hemodynamic aging as the consequence of structural changes associated with early vascular aging (EVA)

Aging and Disease

Volumn 5, Issue 2, 2014, Pages 109-113

  Nilsson, Peter M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aging; Arterial stiffness; Blood pressure; Cardiac; Haemodynamic; Vasculature

Indexed keywords

EID: 84916884031     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500109     Document Type: Review

References (27)

1. Nilsson PM, Lurbe E, Laurent S (2008). The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome (review). J Hypertens, 26:1049-1057.
2. Nilsson PM, Boutouyrie P, Laurent S (2009). Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension, 54:3-10.
3. Nilsson PM, Boutouyrie P, Cunha P, Kotsis V, Narkiewicz K, Parati G, Rietzschel E, Scuteri A, Laurent S (2013). Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens, 8:1517-26.
4. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. (2012). Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens, 30:445-8.
5. Mancia G, Fagard R, Narkiewicz K, et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 31:1281-357.
6. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. (2013). Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol, 25;63:636-46
7. Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, et al. (2009). Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation, 119:243-50.
8. Nilsson PM, Khalili P, Franklin SS (2013). Blood pressure and pulse wave velocity as metrics for evaluating pathologic ageing of the cardiovascular system. Blood Press, 23(1):17-30
9. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. (2010). Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet, 375:895-905.
10. Parati G, Ochoa JE, Salvi P, Lombardi C, Bilo G (2013). Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care, 36 (Suppl 2):S312-24.
11. Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013). Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care, 36:715-21.
12. Mattace-Raso FU, van den Meiracker AH, Bos WJ, van der Cammen TJ, Westerhof BE, Elias-Smale S, et al. (2007). Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam Study. J Hypertens, 25:1421-6.
13. Swierblewska E, Hering D, Kara T, Kunicka K, Kruszewski P, Bieniaszewski L, et al. (2010). An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens, 28:979-84.
14. Barrett-O'Keefe Z, Witman MA, McDaniel J, Fjeldstad AS, Trinity JD, Ives SJ, et al. (2013). Angiotensin II potentiates a-adrenergic vasoconstriction in the elderly. Clin Sci (Lond), 124:413-22.
15. Carnovale V, Paradis ME, Gigleux I, Ramprasath VR, Couture P, Jones PJ, et al. (2013). Correlates of reactive hyperemic index in men and postmenopausal women. Vasc Med, 18:340-6.
16. Lind L, Berglund L, Larsson A, Sundström J (2011). Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation, 123:1545-51.
17. Nemes A, Csanády M, Forster T (2012). Does increased aortic stiffness predict reduced coronary flow velocity reserve in patients with suspected coronary artery disease? Acta Physiol Hung, 99:271-8.
18. Chirinos JA, Rietzschel ER, De Buyzere ML, De Bacquer D, Gillebert TC, Gupta AK, et al; Asklepios investigators (2009). Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension, 54:558-66.
19. O'Rourke MF, Safar ME, Dzau V (2010). The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med, 15:461-8.
20. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee (2006). Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation, 113:1213-25.
21. Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, Boutouyrie P; investigators (2011). Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens, 29:1034-42.
22. Laurent S, Mousseaux E, Boutouyrie P (2013). Arterial stiffness as an imaging biomarker: are all pathways equal? Hypertension, 62:10-2.
23. Steckelings UM, Paulis L, Namsolleck P, Unger T (2012). AT2 receptor agonists: hypertension and beyond. Curr Opin Nephrol Hypertens, 21:142-6.
24. Paulis L, Becker ST, Lucht K, Schwengel K, Slavic S, Kaschina E, et al. (2012). Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension, 59:485-92.
25. Shao C, Yu L, Gao L (2013). Activation of Angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection. Endocrinology, 2013 Dec 3. [Epub ahead of print].
26. Laurent S, Schlaich M, Esler M (2012). New drugs, procedures, and devices for hypertension. Lancet, 380:591-600.
27. Kahan T, Boutouyrie P, Cziráki A, Illyés M, Laurent S, Molnár FT, Scillachi G, Viigimaa M (2013). Aortic stiffness measured by a novel oscillometric method independently predicts cardiovascular morbidity and mortality: A study of 4146 subjects (abstract). European Society of Hypertension (ESH) 23rd Meeting on Hypertension and Vascular Protection, Milan, June 14-17.